Twice-yearly exams unnecessary for patients taking quetiapine.
Gaynes
Bruce I
BI
D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002386:Cataract / Q000139:chemically induced*; D003987:Dibenzothiazepines / Q000009:adverse effects*; D016903:Drug Monitoring; D017408:Guidelines as Topic; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects; D007908:Lens, Crystalline / Q000187:drug effects*; D010808:Physical Examination / Q000706:statistics & numerical data*; D000069348:Quetiapine Fumarate
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000069348:Quetiapine Fumarate